21 Oct 2022 ExeVir Bio forges ahead with unique next generation COVID-19 therapy and appoints Dr. Jeanne Bolger as Chair of the Board of Directors Member news
11 Oct 2022 KU Leuven researchers discover possible new treatment method for metastatic prostate cancer Member news
22 Sep 2022 Researchers identify which cancer cell subpopulations cause tumor growth and metastasis Member news
12 Sep 2022 ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers Member news
07 Sep 2022 New three-year BIMZELX®▼ (bimekizumab) data reinforce long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis Member news
31 Aug 2022 reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration Member news
22 Jun 2022 Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies Member news
25 May 2022 CureVac partners with myNEO to identify novel antigen targets for mRNA-based cancer vaccine development Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
